NDC 35573-439

Loxapine

Loxapine

Loxapine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Burel Pharmaceuticals, Inc.. The primary component is Loxapine Succinate.

Product ID35573-439_626424e3-f82d-4888-9347-2c64b8889cbd
NDC35573-439
Product TypeHuman Prescription Drug
Proprietary NameLoxapine
Generic NameLoxapine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-05-01
Marketing CategoryANDA /
Application NumberANDA076868
Labeler NameBurel Pharmaceuticals, Inc.
Substance NameLOXAPINE SUCCINATE
Active Ingredient Strength50 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 35573-439-02

100 CAPSULE in 1 BOTTLE (35573-439-02)
Marketing Start Date2021-05-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Loxapine" or generic name "Loxapine"

NDCBrand NameGeneric Name
0378-7005Loxapineloxapine
0378-7010Loxapineloxapine
0378-7025Loxapineloxapine
0378-7050Loxapineloxapine
0527-1394LoxapineLoxapine
0527-1395LoxapineLoxapine
0527-1396LoxapineLoxapine
0527-1397LoxapineLoxapine
0591-0369LoxapineLoxapine
0591-0370LoxapineLoxapine
0591-0371LoxapineLoxapine
0591-0372LoxapineLoxapine
10135-585LoxapineLoxapine succinate
10135-586LoxapineLoxapine succinate
10135-587LoxapineLoxapine succinate
10135-588LoxapineLoxapine succinate
17856-1397LoxapineLoxapine
35573-436LoxapineLoxapine
35573-437LoxapineLoxapine
35573-438LoxapineLoxapine
35573-439LoxapineLoxapine
50090-3099LoxapineLoxapine
50090-3457Loxapineloxapine
50090-4701LoxapineLoxapine
51079-901Loxapineloxapine
68151-2875LoxapineLoxapine
70518-0283LoxapineLoxapine
70518-0347LoxapineLoxapine
70518-0416LoxapineLoxapine
70518-0995LoxapineLoxapine
70518-0346LoxapineLoxapine
70518-1681LoxapineLoxapine
70518-1896LoxapineLoxapine
70518-1792LoxapineLoxapine
51079-902LoxapineLoxapine
51079-903LoxapineLoxapine
70518-2120LoxapineLoxapine
10885-003Adasuveloxapine
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.